Friday, May 17, 2024
Description
To register visit: https://go.osu.edu/neuroappsym
The Department of Neurology at The Ohio State University Wexner Medical Center is proud to present its third Advanced Practice Provider Neurology Symposium. This innovative hybrid event will focus on neurology pharmacology for advanced practice providers.
The purpose of the one-day symposium is to make neurology pharmacology easy to comprehend and disseminate into clinical practice. The symposium will host APP experts who will discuss the pharmacologic management of epilepsy, dementia, Parkinson's, neuro-oncology, cerebral vascular disease, and migraine. The symposium has welcomed over 500 providers, including those practicing in countries outside of the United States.
Dates and Times
Start: 5/17/2024 8:00 AM
End: 5/17/2024 4:30 PM
Objectives
1. Understand the value and incorporate appropriate treatment plans for patients with cerebral vascular disease (CVD)
2. Understand side effects of medications associated with CVD
3. Explore the causes and related pharmacological therapies for treatment of neuropathies.
4. Discuss neuromuscular junction disorders, including Myasthenia Gravis, and the available pharmacological therapies used to treat this condition.
5. Discuss disease modifying therapies for Multiple Sclerosis; Matching DMT to disease course and phenotype.
6. Discuss common medications used for symptom management in Multiple Sclerosis
7. Increase awareness of the clinical indication for commonly used anti-seizure medications (ASM)
8. Improve awareness of common side effects and drug to drug interactions associated with ASMs
9. Increase understanding of the use of ASM in the treatment of co-morbid medical condition
10. Describe the pathophysiology of migraine and the link to CGRP antagonists and 5HTF1 agonists in acute treatment and prevention of this disorder.
11. Identify appropriate candidates for standard of care and novel therapy in migraine acute and preventive treatment.
12. Discuss mechanism of action, potential medication interactions, and potential side effects when using pharmaceutical agents in acute and preventive migraine treatment
Location
Fawcett Center
400 Olentangy Rive Road
Columbus, OH 43214
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 6.50 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.